I'm sure people would have read the shareholder letter dated...

I'm sure people would have read the shareholder letter dated 9/10/18...below is an extract from it along with the PDF. The first opportunity for a   presentation is the 30th October in Melbourne.

In coming weeks, Biotron will brief potential pharmaceutical partners on the trial outcomes. We believe that the successful results from this study will facilitate commercialisation negotiations with these parties.

In parallel, the Company expects to present the detailed data from the clinical trial at conferences in late 2018/early 2019.

BIT Newsletter - October 2018.pdf